Journal
/
/
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
DOI:

08:29 min

October 02, 2014

, , , , , , ,

Chapitres

  • 00:05Titre
  • 02:30Tissue Procurement
  • 04:09Preparation of Materials for Sectioning and Vibratome Settings
  • 05:19Tissue Sectioning, Treatment, and Analyses
  • 06:25Results: Ex Vivo Metastatic Breast Cancer Response to Heat Shock Protein 90 Inhibitor
  • 07:56Conclusion

Summary

Traduction automatique

Established cancer cell lines and xenografts have been the mainstay of cancer research for the past several decades. However, recent evidence suggests that therapeutic response is greatly influenced by the tumor cell microenvironment. Therefore, we have developed an ex vivo analysis of primary tumor specimens for drug development purposes.

Vidéos Connexes

Read Article